Faculty profile

Dean Elterman

Back to faculty

Associate ProfessorDepartment of SurgeryUniversity of Toronto

Dean Elterman

Associate Professor

Department of Surgery

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Scholar ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
129 publications in the last five years, latest in 2026.
Senior (last) author on 28 recent papers, a sign of leading a research group.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

178

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Education

MSc, Clinical Epidemiology & Health Services Research
MD
BSc

Profiles and links

University Profile Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Diagnostic accuracy of intravesical prostatic protrusion (IPP) for bladder outlet obstruction using urodynamics as reference standard: a systematic review and meta-analysis.
World journal of urology · 2026
Corrigendum to "Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction" [Eur. Urol. 89 (2026) 318-331].
European urology · 2026
Erectile dysfunction in primary care: practice patterns, barriers, and opportunities-narrative review.
Sexual medicine · 2026 · senior author

All 178 publications

Latest funding

Medical Cannabis Concentrates for Opioid Use Disorder
CIHR · 2019 · Co-investigator
$100,000

All 1 grants and awards

From the 150 most recent of 178 publications.

Diagnostic accuracy of intravesical prostatic protrusion (IPP) for bladder outlet obstruction using urodynamics as reference standard: a systematic review and meta-analysis.

Han Y, Yaghi MH, Polo J, Elsadany M, Elterman D, Bhojani N, Chughtai B

World journal of urology2026

DOI: 10.1007/s00345-026-06664-y PMID: 42541608

Corrigendum to "Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction" [Eur. Urol. 89 (2026) 318-331].

Franco A, Ditonno F, Manfredi C, Bologna E, Licari LC, Orecchia L, Agró EF, Antonelli A, Arlandis S, Autorino R, Tarcan T, Cornu JN, Elterman D, Kaplan S, Lombardo R, McVary K, Secco S, Cindolo L, Nunzio C

European urology2026

DOI: 10.1016/j.eururo.2026.05.003 PMID: 42236391

Erectile dysfunction in primary care: practice patterns, barriers, and opportunities-narrative review.

Saadat H, Pianezza ML, Elterman D

Sexual medicine2026Senior author

DOI: 10.1093/sexmed/qfag033 PMID: 42232240

Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center.

Fiorido C, Siqueira MHB, Aldoukhi M, Alamri N, Fields E, Bhojani N, Chughtai B, Buksh O, Shprits S, Lajkosz K, Elterman D

Neurourology and urodynamics2026Senior author

DOI: 10.1002/nau.70374 PMID: 42423266

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Liu L, Siqueira MHB, Bhojani N, Chughtai B, Zorn KC, Cindolo L, Ferrari G, Lajkosz K, Fields E, Elterman D

Lower urinary tract symptoms2026Senior author

DOI: 10.1111/luts.70079 PMID: 42414217

Does Aquablation Therapy Improve Lower Urinary Tract Symptoms in Patients Aged ≥ 75 Years With Benign Prostatic Obstruction?

Koike S, Ozawa Y, Nohara S, Ushijima K, Okamoto K, Kayaba T, Yamada M, Aoki K, Odagaki Y, Sakamoto H, Elterman D, Yoshioka K

Lower urinary tract symptoms2026

DOI: 10.1111/luts.70072 PMID: 42272055

Summary Paper on the 2026 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.

Baboudjian M, Creta M, Pyrgidis N, Moris L, Duran MB, de Nunzio C, Elterman D, Hashim H, Herrmann TRW, Karavitakis M, Malde S, Netsch C, Rieken M, Sakalis V, Tutolo M, Schouten N, Cornu JN

European urology2026

DOI: 10.1016/j.eururo.2026.03.020 PMID: 41997777

Recalibrating sham-relative superiority thresholds in BPH device trials.

Polo J, Mugglin A, Bhojani N, Zorn K, Kaplan S, Elterman D, Chughtai B

World journal of urology2026

DOI: 10.1007/s00345-026-06645-1 PMID: 42593677

Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.

Fields E, Elterman D, Bhojani N, Polo J, Chughtai B

Expert opinion on drug metabolism & toxicology2026

DOI: 10.1080/17425255.2026.2725917 PMID: 42658049

What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment.

Baboudjian M, Nunzio C, Elterman D, Creta M, Pyrgidis N, Moris L, Duran MB, Hashim H, Karavitakis M, Malde S, Netsch C, Rieken M, Sakalis V, Schouten N, Tutolo M, Herrmann TR, Cornu JN, European Association of Urology (EAU) Guidelines Panel on Management of Non-neurogenic Male LUTS

European urology2026

DOI: 10.1016/j.eururo.2026.05.006 PMID: 42285836

Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Dean Elterman

Research

Latest papers

Latest funding

Diagnostic accuracy of intravesical prostatic protrusion (IPP) for bladder outlet obstruction using urodynamics as reference standard: a systematic review and meta-analysis.

Corrigendum to "Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction" [Eur. Urol. 89 (2026) 318-331].

Erectile dysfunction in primary care: practice patterns, barriers, and opportunities-narrative review.

Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center.

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Does Aquablation Therapy Improve Lower Urinary Tract Symptoms in Patients Aged ≥ 75 Years With Benign Prostatic Obstruction?

Summary Paper on the 2026 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.

Recalibrating sham-relative superiority thresholds in BPH device trials.

Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.

What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment.

Medical Cannabis Concentrates for Opioid Use Disorder

Frequent collaborators

Alan So

Larry Goldenberg

Antonio Finelli

Mina Tadrous

Edward Matsumoto

Daniel Santa Mina

Conrad Maciejewski

Ryan Flannigan

Paul Ritvo

Paul Ritvo

Tara Gomes

Jackie Bender

Blayne Welk

Gerald Brock

Jeffrey Campbell

Andrei Krassioukov

Kari Tikkinen

Emily Belita

Deborah Mcleod

Wanrudee Isaranuwatchai

Sarah Neil-Sztramko

Neil Fleshner

Nathan Perlis

ANDREW FEIFER

Dean Elterman

Research

Latest papers

Latest funding

Diagnostic accuracy of intravesical prostatic protrusion (IPP) for bladder outlet obstruction using urodynamics as reference standard: a systematic review and meta-analysis.

Corrigendum to "Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction" [Eur. Urol. 89 (2026) 318-331].

Erectile dysfunction in primary care: practice patterns, barriers, and opportunities-narrative review.

Long-Term Outcomes of Sacral Neuromodulation Explantation: A 12-Year Experience at a High-Volume Tertiary Center.

Real-World Long-Term Outcomes of Rez&#x16b;m Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Does Aquablation Therapy Improve Lower Urinary Tract Symptoms in Patients Aged &#x2265;&#x2009;75&#x2009;Years With Benign Prostatic Obstruction?

Summary Paper on the 2026 European Association of Urology Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms.

Recalibrating sham-relative superiority thresholds in BPH device trials.

Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and &#x3b2;-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.

What is the Standard Comparator of Minimally Invasive Surgical Therapies (MIST) for Benign Prostatic Obstruction? Medical Versus Surgical Treatment.

Medical Cannabis Concentrates for Opioid Use Disorder

Frequent collaborators

Alan So

Larry Goldenberg

Antonio Finelli

Mina Tadrous

Edward Matsumoto

Daniel Santa Mina

Conrad Maciejewski

Ryan Flannigan

Paul Ritvo

Paul Ritvo

Tara Gomes

Jackie Bender

Blayne Welk

Gerald Brock

Jeffrey Campbell

Andrei Krassioukov

Kari Tikkinen

Emily Belita

Deborah Mcleod

Wanrudee Isaranuwatchai

Sarah Neil-Sztramko

Neil Fleshner

Nathan Perlis

ANDREW FEIFER

Real-World Long-Term Outcomes of Rezūm Therapy for Large-Volume Benign Prostatic Hyperplasia: A Multicenter Cohort Study.

Does Aquablation Therapy Improve Lower Urinary Tract Symptoms in Patients Aged ≥ 75 Years With Benign Prostatic Obstruction?

Pharmacologic and clinical considerations of phosphodiesterase type 5 inhibitors and β-adrenergic receptor type 3 agonists for lower urinary tract symptoms and benign prostatic hyperplasia.